Asia-Pacific Cancer Gene Therapy Market Report 2017

Table of Contents

Asia-Pacific Cancer Gene Therapy Market Report 2017
1 Cancer Gene Therapy Overview
1.1 Product Overview and Scope of Cancer Gene Therapy
1.2 Classification of Cancer Gene Therapy by Product Category
1.2.1 Asia-Pacific Cancer Gene Therapy Market Size (Sales) Comparison by Types (2012-2022)
1.2.2 Asia-Pacific Cancer Gene Therapy Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Insertion of new genes into the body
1.2.4 Other
1.3 Asia-Pacific Cancer Gene Therapy Market by Application/End Users
1.3.1 Asia-Pacific Cancer Gene Therapy Sales (Volume) and Market Share Comparison by Applications (2012-2022)
1.3.2 Hospitals
1.3.3 Diagnostic Centres
1.3.4 Drug Manufacturers
1.3.5 Research Institutes
1.4 Asia-Pacific Cancer Gene Therapy Market by Region
1.4.1 Asia-Pacific Cancer Gene Therapy Market Size (Value) Comparison by Region (2012-2022)
1.4.2 China Status and Prospect (2012-2022)
1.4.3 Japan Status and Prospect (2012-2022)
1.4.4 South Korea Status and Prospect (2012-2022)
1.4.5 Taiwan Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.4.7 Southeast Asia Status and Prospect (2012-2022)
1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of Cancer Gene Therapy (2012-2022)
1.5.1 Asia-Pacific Cancer Gene Therapy Sales and Growth Rate (2012-2022)
1.5.2 Asia-Pacific Cancer Gene Therapy Revenue and Growth Rate (2012-2022)

2 Asia-Pacific Cancer Gene Therapy Competition by Players/Suppliers, Region, Type and Application
2.1 Asia-Pacific Cancer Gene Therapy Market Competition by Players/Suppliers
2.1.1 Asia-Pacific Cancer Gene Therapy Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Asia-Pacific Cancer Gene Therapy Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific Cancer Gene Therapy (Volume and Value) by Type
2.2.1 Asia-Pacific Cancer Gene Therapy Sales and Market Share by Type (2012-2017)
2.2.2 Asia-Pacific Cancer Gene Therapy Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific Cancer Gene Therapy (Volume) by Application
2.4 Asia-Pacific Cancer Gene Therapy (Volume and Value) by Region
2.4.1 Asia-Pacific Cancer Gene Therapy Sales and Market Share by Region (2012-2017)
2.4.2 Asia-Pacific Cancer Gene Therapy Revenue and Market Share by Region (2012-2017)

3 China Cancer Gene Therapy (Volume, Value and Sales Price)
3.1 China Cancer Gene Therapy Sales and Value (2012-2017)
3.1.1 China Cancer Gene Therapy Sales Volume and Growth Rate (2012-2017)
3.1.2 China Cancer Gene Therapy Revenue and Growth Rate (2012-2017)
3.1.3 China Cancer Gene Therapy Sales Price Trend (2012-2017)
3.2 China Cancer Gene Therapy Sales Volume and Market Share by Type
3.3 China Cancer Gene Therapy Sales Volume and Market Share by Application

4 Japan Cancer Gene Therapy (Volume, Value and Sales Price)
4.1 Japan Cancer Gene Therapy Sales and Value (2012-2017)
4.1.1 Japan Cancer Gene Therapy Sales Volume and Growth Rate (2012-2017)
4.1.2 Japan Cancer Gene Therapy Revenue and Growth Rate (2012-2017)
4.1.3 Japan Cancer Gene Therapy Sales Price Trend (2012-2017)
4.2 Japan Cancer Gene Therapy Sales Volume and Market Share by Type
4.3 Japan Cancer Gene Therapy Sales Volume and Market Share by Application

5 South Korea Cancer Gene Therapy (Volume, Value and Sales Price)
5.1 South Korea Cancer Gene Therapy Sales and Value (2012-2017)
5.1.1 South Korea Cancer Gene Therapy Sales Volume and Growth Rate (2012-2017)
5.1.2 South Korea Cancer Gene Therapy Revenue and Growth Rate (2012-2017)
5.1.3 South Korea Cancer Gene Therapy Sales Price Trend (2012-2017)
5.2 South Korea Cancer Gene Therapy Sales Volume and Market Share by Type
5.3 South Korea Cancer Gene Therapy Sales Volume and Market Share by Application

6 Taiwan Cancer Gene Therapy (Volume, Value and Sales Price)
6.1 Taiwan Cancer Gene Therapy Sales and Value (2012-2017)
6.1.1 Taiwan Cancer Gene Therapy Sales Volume and Growth Rate (2012-2017)
6.1.2 Taiwan Cancer Gene Therapy Revenue and Growth Rate (2012-2017)
6.1.3 Taiwan Cancer Gene Therapy Sales Price Trend (2012-2017)
6.2 Taiwan Cancer Gene Therapy Sales Volume and Market Share by Type
6.3 Taiwan Cancer Gene Therapy Sales Volume and Market Share by Application

7 India Cancer Gene Therapy (Volume, Value and Sales Price)
7.1 India Cancer Gene Therapy Sales and Value (2012-2017)
7.1.1 India Cancer Gene Therapy Sales Volume and Growth Rate (2012-2017)
7.1.2 India Cancer Gene Therapy Revenue and Growth Rate (2012-2017)
7.1.3 India Cancer Gene Therapy Sales Price Trend (2012-2017)
7.2 India Cancer Gene Therapy Sales Volume and Market Share by Type
7.3 India Cancer Gene Therapy Sales Volume and Market Share by Application

8 Southeast Asia Cancer Gene Therapy (Volume, Value and Sales Price)
8.1 Southeast Asia Cancer Gene Therapy Sales and Value (2012-2017)
8.1.1 Southeast Asia Cancer Gene Therapy Sales Volume and Growth Rate (2012-2017)
8.1.2 Southeast Asia Cancer Gene Therapy Revenue and Growth Rate (2012-2017)
8.1.3 Southeast Asia Cancer Gene Therapy Sales Price Trend (2012-2017)
8.2 Southeast Asia Cancer Gene Therapy Sales Volume and Market Share by Type
8.3 Southeast Asia Cancer Gene Therapy Sales Volume and Market Share by Application

9 Australia Cancer Gene Therapy (Volume, Value and Sales Price)
9.1 Australia Cancer Gene Therapy Sales and Value (2012-2017)
9.1.1 Australia Cancer Gene Therapy Sales Volume and Growth Rate (2012-2017)
9.1.2 Australia Cancer Gene Therapy Revenue and Growth Rate (2012-2017)
9.1.3 Australia Cancer Gene Therapy Sales Price Trend (2012-2017)
9.2 Australia Cancer Gene Therapy Sales Volume and Market Share by Type
9.3 Australia Cancer Gene Therapy Sales Volume and Market Share by Application

10 Asia-Pacific Cancer Gene Therapy Players/Suppliers Profiles and Sales Data
10.1 Cell Genesys
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Cancer Gene Therapy Product Category, Application and Specification
10.1.2.1 Product A
10.1.2.2 Product B
10.1.3 Cell Genesys Cancer Gene Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
10.1.4 Main Business/Business Overview
10.2 Advantagene
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Cancer Gene Therapy Product Category, Application and Specification
10.2.2.1 Product A
10.2.2.2 Product B
10.2.3 Advantagene Cancer Gene Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
10.2.4 Main Business/Business Overview
10.3 GenVec
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Cancer Gene Therapy Product Category, Application and Specification
10.3.2.1 Product A
10.3.2.2 Product B
10.3.3 GenVec Cancer Gene Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
10.3.4 Main Business/Business Overview
10.4 BioCancell
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Cancer Gene Therapy Product Category, Application and Specification
10.4.2.1 Product A
10.4.2.2 Product B
10.4.3 BioCancell Cancer Gene Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
10.4.4 Main Business/Business Overview
10.5 Celgene and Epeius Biotechnologies
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Cancer Gene Therapy Product Category, Application and Specification
10.5.2.1 Product A
10.5.2.2 Product B
10.5.3 Celgene and Epeius Biotechnologies Cancer Gene Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
10.5.4 Main Business/Business Overview
10.6 Introgen Therapeutics
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Cancer Gene Therapy Product Category, Application and Specification
10.6.2.1 Product A
10.6.2.2 Product B
10.6.3 Introgen Therapeutics Cancer Gene Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
10.6.4 Main Business/Business Overview
10.7 ZIOPHARM Oncology
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Cancer Gene Therapy Product Category, Application and Specification
10.7.2.1 Product A
10.7.2.2 Product B
10.7.3 ZIOPHARM Oncology Cancer Gene Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
10.7.4 Main Business/Business Overview
10.8 MultiVir
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Cancer Gene Therapy Product Category, Application and Specification
10.8.2.1 Product A
10.8.2.2 Product B
10.8.3 MultiVir Cancer Gene Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
10.8.4 Main Business/Business Overview
10.9 Shenzhen SiBiono GeneTech
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Cancer Gene Therapy Product Category, Application and Specification
10.9.2.1 Product A
10.9.2.2 Product B
10.9.3 Shenzhen SiBiono GeneTech Cancer Gene Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
10.9.4 Main Business/Business Overview

11 Cancer Gene Therapy Manufacturing Cost Analysis
11.1 Cancer Gene Therapy Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Cancer Gene Therapy

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Cancer Gene Therapy Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Cancer Gene Therapy Major Manufacturers in 2016
12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List

14 Market Effect Factors Analysis
14.1 Technology Progress/Risk
14.1.1 Substitutes Threat
14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 Asia-Pacific Cancer Gene Therapy Market Forecast (2017-2022)
15.1 Asia-Pacific Cancer Gene Therapy Sales Volume, Revenue and Price Forecast (2017-2022)
15.1.1 Asia-Pacific Cancer Gene Therapy Sales Volume and Growth Rate Forecast (2017-2022)
15.1.2 Asia-Pacific Cancer Gene Therapy Revenue and Growth Rate Forecast (2017-2022)
15.1.3 Asia-Pacific Cancer Gene Therapy Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific Cancer Gene Therapy Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
15.2.1 Asia-Pacific Cancer Gene Therapy Sales Volume and Growth Rate Forecast by Region (2017-2022)
15.2.2 Asia-Pacific Cancer Gene Therapy Revenue and Growth Rate Forecast by Region (2017-2022)
15.2.3 China Cancer Gene Therapy Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.4 Japan Cancer Gene Therapy Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.5 South Korea Cancer Gene Therapy Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.6 Taiwan Cancer Gene Therapy Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.7 India Cancer Gene Therapy Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.8 Southeast Asia Cancer Gene Therapy Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.9 Australia Cancer Gene Therapy Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific Cancer Gene Therapy Sales, Revenue and Price Forecast by Type (2017-2022)
15.3.1 Asia-Pacific Cancer Gene Therapy Sales Forecast by Type (2017-2022)
15.3.2 Asia-Pacific Cancer Gene Therapy Revenue Forecast by Type (2017-2022)
15.3.3 Asia-Pacific Cancer Gene Therapy Price Forecast by Type (2017-2022)
15.4 Asia-Pacific Cancer Gene Therapy Sales Forecast by Application (2017-2022)

16 Research Findings and Conclusion

17 Appendix
17.1 Methodology/Research Approach
17.1.1 Research Programs/Design
17.1.2 Market Size Estimation
17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
17.2.1 Secondary Sources
17.2.2 Primary Sources
17.3 Disclaimer



List of Tables and Figures

Figure Product Picture of Cancer Gene Therapy
Figure Asia-Pacific Cancer Gene Therapy Sales Volume (K Units) by Type (2012-2022)
Figure Asia-Pacific Cancer Gene Therapy Sales Volume Market Share by Type (Product Category) in 2016
Figure Insertion of new genes into the body Product Picture
Figure Other Product Picture
Figure Asia-Pacific Cancer Gene Therapy Sales (K Units) by Application (2012-2022)
Figure Asia-Pacific Sales Market Share of Cancer Gene Therapy by Application in 2016
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Diagnostic Centres Examples
Table Key Downstream Customer in Diagnostic Centres
Figure Drug Manufacturers Examples
Table Key Downstream Customer in Drug Manufacturers
Figure Research Institutes Examples
Table Key Downstream Customer in Research Institutes
Figure Asia-Pacific Cancer Gene Therapy Market Size (Million USD) by Region (2012-2022)
Figure China Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure South Korea Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure Taiwan Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure Australia Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Cancer Gene Therapy Sales Volume (K Units) and Growth Rate (2012-2022)
Figure Asia-Pacific Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Cancer Gene Therapy Market Major Players Product Sales Volume (K Units)(2012-2017)
Table Asia-Pacific Cancer Gene Therapy Sales (K Units) of Key Players/Suppliers (2012-2017)
Table Asia-Pacific Cancer Gene Therapy Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Cancer Gene Therapy Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Cancer Gene Therapy Sales Share by Players/Suppliers
Figure Asia-Pacific Cancer Gene Therapy Market Major Players Product Revenue (Million USD) 2012-2017
Table Asia-Pacific Cancer Gene Therapy Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Asia-Pacific Cancer Gene Therapy Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Cancer Gene Therapy Revenue Share by Players
Figure 2017 Asia-Pacific Cancer Gene Therapy Revenue Share by Players
Table Asia-Pacific Cancer Gene Therapy Sales and Market Share by Type (2012-2017)
Table Asia-Pacific Cancer Gene Therapy Sales Share by Type (2012-2017)
Figure Sales Market Share of Cancer Gene Therapy by Type (2012-2017)
Figure Asia-Pacific Cancer Gene Therapy Sales Growth Rate by Type (2012-2017)
Table Asia-Pacific Cancer Gene Therapy Revenue (Million USD) and Market Share by Type (2012-2017)
Table Asia-Pacific Cancer Gene Therapy Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Cancer Gene Therapy by Type (2012-2017)
Figure Asia-Pacific Cancer Gene Therapy Revenue Growth Rate by Type (2012-2017)
Table Asia-Pacific Cancer Gene Therapy Sales Volume (K Units) and Market Share by Region (2012-2017)
Table Asia-Pacific Cancer Gene Therapy Sales Share by Region (2012-2017)
Figure Sales Market Share of Cancer Gene Therapy by Region (2012-2017)
Figure Asia-Pacific Cancer Gene Therapy Sales Market Share by Region in 2016
Table Asia-Pacific Cancer Gene Therapy Revenue (Million USD) and Market Share by Region (2012-2017)
Table Asia-Pacific Cancer Gene Therapy Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Cancer Gene Therapy by Region (2012-2017)
Figure Asia-Pacific Cancer Gene Therapy Revenue Market Share by Region in 2016
Table Asia-Pacific Cancer Gene Therapy Sales Volume (K Units) and Market Share by Application (2012-2017)
Table Asia-Pacific Cancer Gene Therapy Sales Share (%) by Application (2012-2017)
Figure Asia-Pacific Cancer Gene Therapy Sales Market Share by Application (2012-2017)
Figure Asia-Pacific Cancer Gene Therapy Sales Market Share by Application (2012-2017)
Figure China Cancer Gene Therapy Sales (K Units) and Growth Rate (2012-2017)
Figure China Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Cancer Gene Therapy Sales Price (USD/Unit) Trend (2012-2017)
Table China Cancer Gene Therapy Sales Volume (K Units) by Type (2012-2017)
Table China Cancer Gene Therapy Sales Volume Market Share by Type (2012-2017)
Figure China Cancer Gene Therapy Sales Volume Market Share by Type in 2016
Table China Cancer Gene Therapy Sales Volume (K Units) by Applications (2012-2017)
Table China Cancer Gene Therapy Sales Volume Market Share by Application (2012-2017)
Figure China Cancer Gene Therapy Sales Volume Market Share by Application in 2016
Figure Japan Cancer Gene Therapy Sales (K Units) and Growth Rate (2012-2017)
Figure Japan Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Cancer Gene Therapy Sales Price (USD/Unit) Trend (2012-2017)
Table Japan Cancer Gene Therapy Sales Volume (K Units) by Type (2012-2017)
Table Japan Cancer Gene Therapy Sales Volume Market Share by Type (2012-2017)
Figure Japan Cancer Gene Therapy Sales Volume Market Share by Type in 2016
Table Japan Cancer Gene Therapy Sales Volume (K Units) by Applications (2012-2017)
Table Japan Cancer Gene Therapy Sales Volume Market Share by Application (2012-2017)
Figure Japan Cancer Gene Therapy Sales Volume Market Share by Application in 2016
Figure South Korea Cancer Gene Therapy Sales (K Units) and Growth Rate (2012-2017)
Figure South Korea Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2012-2017)
Figure South Korea Cancer Gene Therapy Sales Price (USD/Unit) Trend (2012-2017)
Table South Korea Cancer Gene Therapy Sales Volume (K Units) by Type (2012-2017)
Table South Korea Cancer Gene Therapy Sales Volume Market Share by Type (2012-2017)
Figure South Korea Cancer Gene Therapy Sales Volume Market Share by Type in 2016
Table South Korea Cancer Gene Therapy Sales Volume (K Units) by Applications (2012-2017)
Table South Korea Cancer Gene Therapy Sales Volume Market Share by Application (2012-2017)
Figure South Korea Cancer Gene Therapy Sales Volume Market Share by Application in 2016
Figure Taiwan Cancer Gene Therapy Sales (K Units) and Growth Rate (2012-2017)
Figure Taiwan Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2012-2017)
Figure Taiwan Cancer Gene Therapy Sales Price (USD/Unit) Trend (2012-2017)
Table Taiwan Cancer Gene Therapy Sales Volume (K Units) by Type (2012-2017)
Table Taiwan Cancer Gene Therapy Sales Volume Market Share by Type (2012-2017)
Figure Taiwan Cancer Gene Therapy Sales Volume Market Share by Type in 2016
Table Taiwan Cancer Gene Therapy Sales Volume (K Units) by Applications (2012-2017)
Table Taiwan Cancer Gene Therapy Sales Volume Market Share by Application (2012-2017)
Figure Taiwan Cancer Gene Therapy Sales Volume Market Share by Application in 2016
Figure India Cancer Gene Therapy Sales (K Units) and Growth Rate (2012-2017)
Figure India Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Cancer Gene Therapy Sales Price (USD/Unit) Trend (2012-2017)
Table India Cancer Gene Therapy Sales Volume (K Units) by Type (2012-2017)
Table India Cancer Gene Therapy Sales Volume Market Share by Type (2012-2017)
Figure India Cancer Gene Therapy Sales Volume Market Share by Type in 2016
Table India Cancer Gene Therapy Sales Volume (K Units) by Application (2012-2017)
Table India Cancer Gene Therapy Sales Volume Market Share by Application (2012-2017)
Figure India Cancer Gene Therapy Sales Volume Market Share by Application in 2016
Figure Southeast Asia Cancer Gene Therapy Sales (K Units) and Growth Rate (2012-2017)
Figure Southeast Asia Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Cancer Gene Therapy Sales Price (USD/Unit) Trend (2012-2017)
Table Southeast Asia Cancer Gene Therapy Sales Volume (K Units) by Type (2012-2017)
Table Southeast Asia Cancer Gene Therapy Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Cancer Gene Therapy Sales Volume Market Share by Type in 2016
Table Southeast Asia Cancer Gene Therapy Sales Volume (K Units) by Applications (2012-2017)
Table Southeast Asia Cancer Gene Therapy Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Cancer Gene Therapy Sales Volume Market Share by Application in 2016
Figure Australia Cancer Gene Therapy Sales (K Units) and Growth Rate (2012-2017)
Figure Australia Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2012-2017)
Figure Australia Cancer Gene Therapy Sales Price (USD/Unit) Trend (2012-2017)
Table Australia Cancer Gene Therapy Sales Volume (K Units) by Type (2012-2017)
Table Australia Cancer Gene Therapy Sales Volume Market Share by Type (2012-2017)
Figure Australia Cancer Gene Therapy Sales Volume Market Share by Type in 2016
Table Australia Cancer Gene Therapy Sales Volume (K Units) by Applications (2012-2017)
Table Australia Cancer Gene Therapy Sales Volume Market Share by Application (2012-2017)
Figure Australia Cancer Gene Therapy Sales Volume Market Share by Application in 2016
Table Cell Genesys Cancer Gene Therapy Basic Information List
Table Cell Genesys Cancer Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Cell Genesys Cancer Gene Therapy Sales (K Units) and Growth Rate (2012-2017)
Figure Cell Genesys Cancer Gene Therapy Sales Market Share in Asia-Pacific (2012-2017)
Figure Cell Genesys Cancer Gene Therapy Revenue Market Share in Asia-Pacific (2012-2017)
Table Advantagene Cancer Gene Therapy Basic Information List
Table Advantagene Cancer Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Advantagene Cancer Gene Therapy Sales (K Units) and Growth Rate (2012-2017)
Figure Advantagene Cancer Gene Therapy Sales Market Share in Asia-Pacific (2012-2017)
Figure Advantagene Cancer Gene Therapy Revenue Market Share in Asia-Pacific (2012-2017)
Table GenVec Cancer Gene Therapy Basic Information List
Table GenVec Cancer Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GenVec Cancer Gene Therapy Sales (K Units) and Growth Rate (2012-2017)
Figure GenVec Cancer Gene Therapy Sales Market Share in Asia-Pacific (2012-2017)
Figure GenVec Cancer Gene Therapy Revenue Market Share in Asia-Pacific (2012-2017)
Table BioCancell Cancer Gene Therapy Basic Information List
Table BioCancell Cancer Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure BioCancell Cancer Gene Therapy Sales (K Units) and Growth Rate (2012-2017)
Figure BioCancell Cancer Gene Therapy Sales Market Share in Asia-Pacific (2012-2017)
Figure BioCancell Cancer Gene Therapy Revenue Market Share in Asia-Pacific (2012-2017)
Table Celgene and Epeius Biotechnologies Cancer Gene Therapy Basic Information List
Table Celgene and Epeius Biotechnologies Cancer Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Celgene and Epeius Biotechnologies Cancer Gene Therapy Sales (K Units) and Growth Rate (2012-2017)
Figure Celgene and Epeius Biotechnologies Cancer Gene Therapy Sales Market Share in Asia-Pacific (2012-2017)
Figure Celgene and Epeius Biotechnologies Cancer Gene Therapy Revenue Market Share in Asia-Pacific (2012-2017)
Table Introgen Therapeutics Cancer Gene Therapy Basic Information List
Table Introgen Therapeutics Cancer Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Introgen Therapeutics Cancer Gene Therapy Sales (K Units) and Growth Rate (2012-2017)
Figure Introgen Therapeutics Cancer Gene Therapy Sales Market Share in Asia-Pacific (2012-2017)
Figure Introgen Therapeutics Cancer Gene Therapy Revenue Market Share in Asia-Pacific (2012-2017)
Table ZIOPHARM Oncology Cancer Gene Therapy Basic Information List
Table ZIOPHARM Oncology Cancer Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure ZIOPHARM Oncology Cancer Gene Therapy Sales (K Units) and Growth Rate (2012-2017)
Figure ZIOPHARM Oncology Cancer Gene Therapy Sales Market Share in Asia-Pacific (2012-2017)
Figure ZIOPHARM Oncology Cancer Gene Therapy Revenue Market Share in Asia-Pacific (2012-2017)
Table MultiVir Cancer Gene Therapy Basic Information List
Table MultiVir Cancer Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure MultiVir Cancer Gene Therapy Sales (K Units) and Growth Rate (2012-2017)
Figure MultiVir Cancer Gene Therapy Sales Market Share in Asia-Pacific (2012-2017)
Figure MultiVir Cancer Gene Therapy Revenue Market Share in Asia-Pacific (2012-2017)
Table Shenzhen SiBiono GeneTech Cancer Gene Therapy Basic Information List
Table Shenzhen SiBiono GeneTech Cancer Gene Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Shenzhen SiBiono GeneTech Cancer Gene Therapy Sales (K Units) and Growth Rate (2012-2017)
Figure Shenzhen SiBiono GeneTech Cancer Gene Therapy Sales Market Share in Asia-Pacific (2012-2017)
Figure Shenzhen SiBiono GeneTech Cancer Gene Therapy Revenue Market Share in Asia-Pacific (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Unit) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cancer Gene Therapy
Figure Manufacturing Process Analysis of Cancer Gene Therapy
Figure Cancer Gene Therapy Industrial Chain Analysis
Table Raw Materials Sources of Cancer Gene Therapy Major Manufacturers in 2016
Table Major Buyers of Cancer Gene Therapy
Table Distributors/Traders List
Figure Asia-Pacific Cancer Gene Therapy Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Cancer Gene Therapy Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Cancer Gene Therapy Price (USD/Unit) and Trend Forecast (2017-2022)
Table Asia-Pacific Cancer Gene Therapy Sales Volume (K Units) Forecast by Region (2017-2022)
Figure Asia-Pacific Cancer Gene Therapy Sales Volume Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Cancer Gene Therapy Sales Volume Market Share Forecast by Region in 2022
Table Asia-Pacific Cancer Gene Therapy Revenue (Million USD) Forecast by Region (2017-2022)
Figure Asia-Pacific Cancer Gene Therapy Revenue Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Cancer Gene Therapy Revenue Market Share Forecast by Region in 2022
Figure China Cancer Gene Therapy Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure China Cancer Gene Therapy Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Cancer Gene Therapy Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan Cancer Gene Therapy Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure South Korea Cancer Gene Therapy Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure South Korea Cancer Gene Therapy Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Taiwan Cancer Gene Therapy Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Taiwan Cancer Gene Therapy Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Cancer Gene Therapy Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure India Cancer Gene Therapy Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Cancer Gene Therapy Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Cancer Gene Therapy Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Australia Cancer Gene Therapy Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Australia Cancer Gene Therapy Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Asia-Pacific Cancer Gene Therapy Sales (K Units) Forecast by Type (2017-2022)
Figure Asia-Pacific Cancer Gene Therapy Sales Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Cancer Gene Therapy Revenue (Million USD) Forecast by Type (2017-2022)
Figure Asia-Pacific Cancer Gene Therapy Revenue Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Cancer Gene Therapy Price (USD/Unit) Forecast by Type (2017-2022)
Table Asia-Pacific Cancer Gene Therapy Sales (K Units) Forecast by Application (2017-2022)
Figure Asia-Pacific Cancer Gene Therapy Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.

Menu 3

Eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo.